Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab
Clinical trial NCT07015333 · COMPLETED
Trial details
- NCT number
- NCT07015333
- Sponsor
- Commonwealth Healthcare Corporation
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-01
- Primary completion
- 2024-11-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.